Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas

ConclusionsThe present study suggests that overexpression ofCD44 is associated with a poor prognosis for grade II/III glioma patients. Moreover, our findings suggest thatCD44 could serve as a prognostic biomarker in grade II/III glioma patients.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research